Dezhan HealthCare Co Ltd (SHE:000813) — Market Cap & Net Worth
Market Cap & Net Worth: Dezhan HealthCare Co Ltd (000813)
Dezhan HealthCare Co Ltd (SHE:000813) has a market capitalization of $920.62 Million (CN¥6.29 Billion) as of June 19, 2026. Listed on the SHE stock exchange, this China-based company holds position #9431 globally and #2444 in its home market, demonstrating a -2.28% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Dezhan HealthCare Co Ltd's stock price CN¥3.00 by its total outstanding shares 2097105540 (2.10 Billion). Review 000813 liabilities breakdown to assess the company's total debt and financial obligations.
Dezhan HealthCare Co Ltd Market Cap History: 2016 to 2026
Dezhan HealthCare Co Ltd's market capitalization history from 2016 to 2026. Data shows change from $2.84 Billion to $920.62 Million (-8.90% CAGR).
Dezhan HealthCare Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Dezhan HealthCare Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
2.97x
Dezhan HealthCare Co Ltd's market cap is 2.97 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $2.84 Billion | $1.44 Billion | $661.67 Million | 1.97x | 4.29x |
| 2017 | $2.56 Billion | $2.22 Billion | $797.18 Million | 1.15x | 3.21x |
| 2018 | $2.71 Billion | $3.29 Billion | $930.53 Million | 0.82x | 2.91x |
| 2019 | $1.85 Billion | $1.77 Billion | $336.92 Million | 1.04x | 5.50x |
| 2020 | $1.31 Billion | $962.87 Million | $284.54 Million | 1.36x | 4.59x |
| 2021 | $1.25 Billion | $734.48 Million | -$57.58 Million | 1.70x | N/A |
| 2022 | $1.14 Billion | $570.86 Million | -$46.95 Million | 1.99x | N/A |
| 2023 | $1.00 Billion | $498.09 Million | $83.31 Million | 2.01x | 12.04x |
| 2024 | $960.51 Million | $466.49 Million | -$20.41 Million | 2.06x | N/A |
| 2025 | $1.18 Billion | $396.81 Million | -$345.42 Million | 2.97x | N/A |
Competitor Companies of 000813 by Market Capitalization
Companies near Dezhan HealthCare Co Ltd in the global market cap rankings as of June 19, 2026.
Key companies related to Dezhan HealthCare Co Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #513 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #560 globally with a market cap of $48.78 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #631 globally with a market cap of $43.86 Billion USD ( CN¥299.75 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #634 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #513 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #560 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $43.27 |
| #631 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $43.86 Billion | CN¥46.99 |
| #634 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €13.30 |
Dezhan HealthCare Co Ltd Historical Marketcap From 2016 to 2026
Between 2016 and today, Dezhan HealthCare Co Ltd's market cap moved from $2.84 Billion to $ 920.62 Million, with a yearly change of -8.90%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥920.62 Million | -21.88% |
| 2025 | CN¥1.18 Billion | +22.68% |
| 2024 | CN¥960.51 Million | -4.28% |
| 2023 | CN¥1.00 Billion | -11.86% |
| 2022 | CN¥1.14 Billion | -8.85% |
| 2021 | CN¥1.25 Billion | -4.37% |
| 2020 | CN¥1.31 Billion | -29.57% |
| 2019 | CN¥1.85 Billion | -31.48% |
| 2018 | CN¥2.71 Billion | +5.76% |
| 2017 | CN¥2.56 Billion | -9.77% |
| 2016 | CN¥2.84 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 18th, 2026 the market cap of Dezhan HealthCare Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $920.62 Million USD |
| MoneyControl | $920.62 Million USD |
| MarketWatch | $920.62 Million USD |
| marketcap.company | $920.62 Million USD |
| Reuters | $920.62 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Dezhan HealthCare Co Ltd
Dezhan Healthcare Company Limited engages in the research and development, manufacture, and sale of cardiovascular and cerebrovascular drugs in the People's Republic of China. The company offers atorvastatin calcium tablets, amlodipine atorvastatin calcium tablets, trimetazidine hydrochloride capsules, amiodarone hydrochloride tablets, as well as other drugs, including famciclovir tablets, azathi… Read more